semaglutide approved for mash 🎉Exciting news that is now FDA (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Wegovy® (semaglutide injection) Receives Conditional

More importantly, cardiovascular and renal outcome studies have demonstrated that GLP-1RAs and related multi-receptor agonists not only lower body weight and blood glucose but also significantly reduce the risk of major adverse cardiovascular events (MACE) and the worsening of renal function

Do not abandon natural approaches during your worst days

Carbohydrates also offer a great chance to include more soluble and insoluble fiber in your diet, which helps reduce side effects of the medication

Weekly timing should remain consistent, with injections administered on the same day each week

The study also found that women who had taken GLP-1s before getting pregnant or early in their pregnancy had a 34% higher risk of preterm delivery, meaning their babies were born before 37 weeks